Memoplant forte 80 mg > He hoʻomaʻemaʻe a me ke pale aku

mea waiwai: ʻO ka papa papaʻu he 80 mg o ka maloʻo maloʻo (EGb 761 ®) mai nā lau o Ginkgo biloba (Ginkgo biloba) (35-67: 1), i hoʻonohonoho ʻia i 17.6-21.6 mg o Ginkgo flavonoids a hiki i ka 4.32 -5.28 mg o terpenlactones, kahi o ka 2.24-2.72 mg o nā ginkgolides A, B, C a me 2.08-2.56 mg ka bilobalide ʻaʻole iʻoi aku ma mua o 0.4 μg o nā waikawa ginkgolic (mea kikoʻī: acetone 60% ( m / m)),

nā mea hoʻowalewale: lactose, microcrystalline cellulose starch corn silikone dioxide colloidal sodium croscarmellose sodium, magnesium hypromellose stearate, macrogol 1500, titanium dioxide (E 171) iron oxide red (E172) iron oxide brown (E172) emulsion anti-foam SE2 (dimethicone, silony , kaomi sorbic) talc.

Pākuʻi helu. Nā papa hana ʻulaʻī.

Nā pilikino pilikino a me nā huahana: ʻulaʻula, hoʻoneʻe, nā ʻāpana pōpoki, pale ʻia nā kiʻi ʻoniʻoni.

ʻO nā waiwai Pharmacological

ʻO kahi hoʻomākaukau lāʻau e hoʻomaʻamaʻa i ka metabolism i loko o nā kōpona, nā mea o ka rheological o ke koko a me ka microcirculation. Hoʻonui ʻo ia i ka kaila koko cerebral a me ka hoʻolako o ka oxygen a me ka glucose i ka lolo, pale i ka hōʻuluʻulu ʻana o nā ʻāpana koko ʻōmaʻomaʻo, a pale aku i ka hoʻoulu ʻia o platelet. Hōʻike i ka hopena hoʻoponopono kānāwai-hilinaʻi ma ka ʻōnaehana vascular, hoʻoulu i ka hana o ka laxative factor endothelium (nitric oxide - NO), e hoʻonui i nā lāʻau liʻiliʻi, hoʻonui i ka leo venous, a pēlā e hoʻoponopono ai i nā kīʻaha koko. Hoʻēmi i ka permeability o ka paia vascular (decongestant hopena ʻelua i ka pae o ka lolo a i ka periphery). Loaʻa ia i kahi hopena antithrombotic (ma muli o ka hoʻomau ʻana o nā membrane o nā platelets a me nā kaila koko ʻula, nā hopena i ke kāpili ʻana o ka prostaglandins, kahi e hoʻoneʻe ana i ka hopena o nā meaola biologically aktibo a me ka thrombocyte-activating factor).

ʻO ka waiwai ikaika ʻo Ginkgo biloba dry standardized extract (EGb 761 ®): 24% heterosides a me 6% ginkgolide-bilobalides (Ginkgolide A, B a me ka bilobalide C).

Ke hoʻokō ʻia, ka bioavailability o ginkgolide A, B a me ka bilobalide C ka mea 80-90%. Loaʻa ka ʻike kiʻekiʻe loa i nā hola 1-2 ma hope o ka lawe ʻana i ka lāʻau lapaʻau. ʻO ka hapalua ola e like me 4:00 (bilobalide, ginkgolide A) a me 10:00 (ginkgolide B).

ʻAʻole hoʻokaʻawale kēia mau mea i loko o ke kino, aneane pau loa i loko o ka pāʻai, liʻiliʻi ka liʻiliʻi ma nā feces.

I ka wehe ʻana o nā kumuwaiwai o nā ʻano ʻano kumu (discirculatory encephalopathy (dementia) ma muli o ke kaʻe, hōʻeha ka traumatic brain, i ka wā ʻelemakule, ka mea i hōʻike ʻia e nā pilikia o ka hopohopo a me / a hoʻomanaʻo paha, i ka hoʻoneʻe ʻana i nā naʻauao noʻonoʻo, nā manaʻo hopohopo, ka hiamoe hiamoe) a me ka hemahema o ka neurosensory o nā ʻano genesis (senile degeneration macula, diabetes retinopathy)
ka paʻapū intermittent i ka pale mau i ka lalo o ka pākaukau o ka wāwae (II degree e like me Fontaine)
ka ʻikeʻana o ka maʻi vascular, kahi emi i kona koʻikoʻi,
ka hoʻolohe ʻana i ka luhi, ka tinnitus, nā dizz a me ka hoʻopuni ʻana i ka hoʻohuihui o ka nui o ke vascular,
ʻO ka maʻi o Raynaud.

Hoʻopili me nā lāʻau lapaʻau a me nā ʻano ʻē aʻe ʻē aʻe

ʻAʻole e hiki ke hoʻoholo ʻia nā pilina me nā lāʻau e hoʻōki ana i ke koikoi koko. I kahi papa hoʻomohala i hoʻomalu ʻia ka ʻimi, ua ʻike ʻia nā haumāna ʻelua makapō ma luna o 50 mau kumuhana no 7 mau lā, ʻaʻole i ʻike ʻia kahi pili o EGb 761 ® (i kēlā me kēia lā o 240 mg) me ka acetylsalicylic acid (i kēlā me kēia lā o 500 mg) e ʻike ʻia.

Hōʻike nā hōʻailona mua o ka holomua ma hope o ka mahina 1 mai ka hoʻomaka ʻana o ka mālama ʻana. ʻAʻole hiki ke hoʻokaʻawale ʻia nā hoʻomākaukau e loaʻa ana kahi neʻe mai nā lau o ka ginkgo biloba e kōkua i ka loaʻa ʻana o nā mea i hopu ai i nā mea maʻi me ka epilepsy.

No ka mea i loko o kēia lāʻau lapaʻau ka lactose, ua contraindicated i loko o nā mea maʻi me ka galactosemia congenital, glucose a me ka galactose malabsorption syndrome, a i ʻole lactase deficiency.